This brings Neuralink’s total funding up to about $66.3 million; in August 2017, the company reported raising $27 million of a target of $100 million. At the time, however, despite the filing, Mr. Musk wrote in a tweet that “Neuralink is not raising money.”
The Tesla and SpaceX CEO founded Neuralink in 2016 with a goal of creating a brain-computer interface to enhance the human brain using artificial intelligence. Though Mr. Musk has yet to unveil this technology, he has hinted several times in recent months that the company will have an announcement to make “soon.”
More articles about AI:
FDA clears AI tool to flag pulmonary embolism in CT scans
3 new AI-enabled FDA ‘Breakthrough Devices’: an Alzheimer’s-detecting retinal scanner, a kidney disease diagnostic & more
Deep learning system detects ACL tears as accurately as trained radiologists
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
